{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:14:22Z","timestamp":1790284462733,"version":"4.1.0"},"reference-count":37,"publisher":"Korean Pediatric Society","issue":"12","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["e-cep.org"],"crossmark-restriction":true},"short-container-title":["Clin Exp Pediatr"],"published-print":{"date-parts":[[2025,12,15]]},"abstract":"<jats:p>Background: Iron overload is a hallmark complication in patients with transfusion-dependent \u03b2-thalassemia major, primarily resulting from ineffective erythropoiesis, repeated blood transfusions, and increased gastrointestinal iron absorption. This iron accumulation, reflected in elevated serum ferritin levels, has been implicated in immune dysregulation. Natural killer (NK) cells are a pivotal component of the innate immune system, known for their cytotoxic activity and cytokine secretion, particularly interferon-gamma (IFN-\u03b3). Disruption in NK cell subsets may compromise immune surveillance and defense against infections in these patients.Purpose: To evaluate the distribution and function of NK cell subpopulations in pediatric patients with transfusion-dependent \u03b2-thalassemia major and explore their association with iron overload and immune dysfunction.Methods: Seventy-eight children were enrolled and divided into 2 groups: 43 pediatric patients with transfusion-dependent \u03b2-thalassemia major and 35 apparently healthy controls. NK cells and their subsets (CD56bright, CD56dim, CD56neg) were quantified using multicolor flow cytometry. Serum IFN-\u03b3 levels were measured to assess NK cell cytokine activity. Ferritin levels were used as a marker of iron overload.Results: Patients showed a significant reduction in CD56bright and CD56dim NK cells compared to controls (P&lt;0.001), indicating impaired NK-mediated immunity. Conversely, the CD56neg subset, associated with dysfunctional or altered NK cell phenotypes, was significantly elevated in patients (P&lt;0.002). A strong negative correlation was observed between serum ferritin levels and CD56dim NK cells (P=0.003), suggesting that iron overload suppresses cytotoxic NK activity. Moreover, IFN-\u03b3 levels inversely correlated with CD56bright (P&lt;0.001) and CD56dim (P=0.019) cells, but positively correlated with CD56neg cells, implicating this altered subset as a potential compensatory source of cytokine production.Conclusion: Hyperferritinemia in pediatric \u03b2-thalassemia major is linked to a dysregulated NK cell profile, marked by suppression of functional CD56bright and CD56dim subsets and expansion of the atypical CD56neg subset. These alterations may compromise innate immunity and contribute to increased infection risk. Our findings highlight the immunomodulatory impact of iron overload and underscore the clinical importance of monitoring NK cell dynamics in thalassemia management.<\/jats:p>","DOI":"10.3345\/cep.2025.01046","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T02:12:33Z","timestamp":1757643153000},"page":"981-990","update-policy":"https:\/\/doi.org\/10.3345\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of natural killer cell subpopulations in pediatric patients with transfusion-dependent \u03b2-thalassemia major"],"prefix":"10.3345","volume":"68","author":[{"given":"Fathia Ibrahim","family":"Elbassal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Abdel Rehim","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourhan Hossam Eldin","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai El-Sayad Abd","family":"El-Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1463-9749","authenticated-orcid":true,"given":"Hanan Hassan","family":"El-Sheity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1897","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(22)00536-0"},{"key":"ref2","first-page":"272","volume-title":"Alpha- and beta-thalassemia: rapid evidence review","author":"Baird","year":"2022"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/mph.0000000000002468"},{"key":"ref4","first-page":"1642","volume-title":"","author":"Fairbanks","year":"1999"},{"key":"ref5","volume-title":"","author":"Viprakasit","year":"2014"},{"key":"ref6","first-page":"e2009028","volume-title":"Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications","author":"Ricerca","year":"2009"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i35.4707"},{"key":"ref8","first-page":"342","volume-title":"Transfusion-related immunomodulation","author":"Vlaar","year":"2017"},{"key":"ref9","first-page":"531","volume-title":"Infections in thalassemia: a review","author":"Taher","year":"2011"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1164926"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2022.12.003"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.29313\/gmhc.v9i1.6346"},{"key":"ref13","first-page":"330","volume-title":"","author":"Morilla","year":"2017"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ejh.ejh_3_18"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-016-2140-x"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2006.07.013"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93577"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24119"},{"key":"ref19","first-page":"137","volume-title":"Red blood cell transfusion in patients undergoing elective primary glioblastoma resection","author":"Neef","year":"2024"},{"key":"ref20","first-page":"354","volume-title":"Effects of iron overload on the immune system","author":"Walker","year":"2000"},{"key":"ref21","first-page":"887","volume-title":"Serum ferritin level affects T lymphocyte CD4, CD8, and CD4\/CD8 ratio in transfusion-dependent beta-thalassemia","author":"Amrita","year":"2020"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199511000-00005"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4161\/onci.23472"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101774"},{"key":"ref25","first-page":"162","volume-title":"A new hope for CD56negCD16pos NK cells as unconventional cytotoxic mediators: an adaptation to chronic diseases","author":"Catherine","year":"2020"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1997.d01-962.x"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.22159\/ajpcr.2018.v11i9.26661"},{"key":"ref28","first-page":"1","volume-title":"Evaluation of cellular immunity for \u03b2-thalassemia major patients in Wasit Thalassemia Center","author":"Fadhil","year":"2017"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189677"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(91)90076-d"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.07.040189.001045"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90051-9"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1159\/000322720"},{"key":"ref34","first-page":"1595","volume-title":"Dynamic coupling of ALCAM to the actin cortex strengthens cell adhesion to CD6","author":"Te Riet","year":"2014"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m113.546754"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2003.10.012"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-126888"}],"container-title":["Clinical and Experimental Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-cep.org\/upload\/pdf\/cep-2025-01046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cep.org\/journal\/view.php?doi=10.3345\/cep.2025.01046","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cep.org\/upload\/pdf\/cep-2025-01046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T01:30:38Z","timestamp":1764552638000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-cep.org\/journal\/view.php?doi=10.3345\/cep.2025.01046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"URL":"https:\/\/doi.org\/10.3345\/cep.2025.01046","relation":{},"ISSN":["2713-4148"],"issn-type":[{"value":"2713-4148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"2025-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-12","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-15","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}